EV-075 (Emergent)

N/A

Report date: 2023/01/08 14:03:51
NME

Base Information

Drug NameEV-075 (Emergent)
Drug Alias NameEV-075-2EV-075
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsHemorrhagic Fever, EbolaInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions Inc
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, EbolaInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A